Preclinical Toxicology Studies For New Drugs and Vaccines.
Abstract
The purpose of this study is to determine specific target organ toxicity, dose-response relationships, and a no adverse effect level of WR6026 in Beagle dogs following thirteen weeks of daily oral administration. In addition, the reversibility of these toxic effects over a 90-day recovery period will be assessed. Treatment was initiated on 5/7/92. Necropsies were conducted on 8/6-7/92 and 11/5-6/92 after the three month treatment period and a three month recovery period, respectively.
Document Details
- Document Type
- Technical Report
- Publication Date
- Dec 07, 1992
- Accession Number
- ADA259275
Entities
People
- Barry S. Levine
Organizations
- University of Illinois at Chicago